PASG
Passage Bio Inc
NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY
$5.00
+0.30% today
Updated 2026-09-11
Market cap
$14.96M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.08
Dividend yield
—
52W range
$3 – $20
Volume
0.0M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C3.3
Quality
D3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-17.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$15.50
+210.00%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -17.52 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-9.18M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-136.13M | $-102.06M | $-64.77M | $-45.52M | $-7.82M |
| EPS | — | — | — | — | $-11.08 |
| Free cash flow | $-123.48M | $-78.41M | $-47.99M | $-31.51M | $-9.18M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Passage Bio Inc trades at $5.00. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -17.52, it sits in the distress.
Frequently asked questions
What is Passage Bio Inc's stock price?
Passage Bio Inc (PASG) trades at $5.00.
Is Passage Bio Inc overvalued?
Passage Bio Inc carries a Smart Value Score of 21/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Passage Bio Inc (PASG)?
The 12-month analyst consensus target is $15.50, about 210.0% above the current $5.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Passage Bio Inc's Altman Z-Score is -17.52, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-320.59%
Beta1.43
50D MA$4.62
200D MA$7.62
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—